Skip to main content
Log in

Autosomal dominant polycystic kidney disease: new role for ultrasound

  • Ultrasound
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To evaluate the accuracy of US in calculating renal volumes and renal resistive index (RRI) that was obtained using a new method in patients with autosomal dominant polycystic kidney disease (ADPKD).

Methods

In this prospective study, US and MRI were performed in 57 patients with ADPKD (31 female and 26 male; age range, 19–79 years) between August 2017 and May 2018. The volumes determined using US and MRI were compared. The ellipsoid formula was re-evaluated using different multipliers. RRI was obtained 1.5–2 cm distal to the outlet of main renal arteries. The relationship between mean RRI, renal function tests, and kidney volumes and difference between mean RRI of ADPKD patients with and without renal failure were investigated using a two-sided independent samples t test and Pearson correlation test. Interobserver agreements for volume assessments and RRI measurements were determined.

Results

By changing the ellipsoid formula, a very good agreement was found (ICC 0.970 for the right kidney and ICC 0.973 for the left kidney). The mean RRI in the right renal artery was 0.61 ± 0.07 and in the left renal artery 0.63 ± 0.06. The mean RRI of ADPKD patients with renal failure was significantly higher than that of patients without renal failure (p = 0.005). There was a significant correlation between mean RRI and renal function tests.

Conclusion

The accuracy of the US in calculating renal volumes increases by adapting the ellipsoid formula. RRI may be used for the management of ADPKD independently of volumes.

Key Points

•The accuracy of ultrasonography for renal volume measurement increases by changing the classical ellipsoid formula.

•Renal resistive index measured by color Doppler ultrasonography is helpful for the management of autosomal dominant polycystic kidney disease.

•The role of Doppler US in autosomal dominant polycystic kidney disease should increase as a result of our findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

ADPKD:

Autosomal dominant polycystic kidney disease

AP:

Maximum anteroposterior distance

BUN:

Blood urea nitrogen

CCC:

Concordance correlation coefficient

eGFR:

Estimated glomerular filtration rate

H:

Maximum renal height

ICC:

Intraclass correlation coefficient

ML:

Maximum mediolateral distance

MRI:

Magnetic resonance imaging

RRI:

Renal resistive index

TKV:

Total kidney volume

US:

Ultrasound

References

  1. Torres VE, Harris PC, Pirson Y (2007) Autosomal dominant polycystic kidney disease. Lancet 369:1287–1301

    Article  Google Scholar 

  2. Sung CK, Kim SH, Ahn C (2008) Grayscale and Doppler ultrasonographic findings reflecting disease severity in autosomal dominant polycystic kidney disease. J Med Ultrasound 16:65–73

    Article  Google Scholar 

  3. Pei Y, Obaji J, Dupuis A et al (2009) Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol 20:205–212

    Article  CAS  Google Scholar 

  4. Nicolau C, Torra R, Badena C et al (1999) Autosomal dominant polycystic kidney disease types 1 and 2: assessment of US sensitivity for diagnosis. Radiology 213:273–276

    Article  CAS  Google Scholar 

  5. Demetriou K, Tziakouri C, Anninou K et al (2000) Autosomal dominant polycystic kidney disease-type 2. Ultrasound, genetic and clinical correlations. Nephrol Dial Transplant 15:205–211

    Article  CAS  Google Scholar 

  6. Grantham JJ, Torres VE, Chapman AB et al (2006) Volume progression in polycystic kidney disease. N Engl J Med 354:2122–2130

    Article  CAS  Google Scholar 

  7. Food and Drug Administration (2016) Qualification of Biomarker-Total Kidney Volume in Studies for Treatment of Autosomal Dominant Polycystic Kidney Disease: Guidance for Industry. Food and Drug Administration, Silver Spring. Available via http://www.fda.gov/downloads/Drugs/Guidances/UCM458483.pdf. Accessed 6 Dec 2018

  8. European Medicines Agency (2015) Draft Qualification Opinion-Total Kidney Volume as a Prognostic Biomarker for Use in Clinical Trials Evaluating Patients with Autosomal Dominant Polycystic Kidney Disease. European Medicines Agency, London Available via http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2015/07/WC500190205.pdf. Accessed 6 Dec 2018

  9. Platt JF, Ellis JH, Rubin JM, DiPietro MA, Sedman AB (1990) Intrarenal arterial Doppler sonography in patients with non-obstructive renal disease: correlation of resistive index with biopsy finding. AJR Am J Roentgenol 154:1223–1227

    Article  CAS  Google Scholar 

  10. Patriquin HB, O’Regan S, Robitaille P, Paltiel H (1989) Hemolytic–uremic syndrome: intrarenal arterial Doppler patterns as a useful guide to therapy. Radiology 172:625–628

    Article  CAS  Google Scholar 

  11. Kim SH, Kim WH, Choi BI, Kim CW (1992) Duplex Doppler US in patients with medical renal disease: resistive index vs serum creatinine level. Clin Radiol 45:85–87

    Article  CAS  Google Scholar 

  12. Chapman AB, Johnson A, Gabow PA et al (1990) The renin angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med 323:1091–1096

    Article  CAS  Google Scholar 

  13. Sawicki M, Walecka A, Rozanski J, Safranow K, Ciechanowski K (2009) Doppler sonography measurements of renal vascular resistance in autosomal-dominant polycystic kidney disease. Med Sci Monit 15:101–104

    Google Scholar 

  14. Bae KT, Tao C, Wang J et al (2013) Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP). Novel approach to estimate kidney and cyst volumes using mid-slice magnetic resonance images in polycystic kidney disease. Am J Nephrol 38:333–341

    Article  Google Scholar 

  15. Bakker J, Olree M, Kaatee R, De Lange EE, Beek FJA (1997) In vitro measurement of kidney size: comparison of ultrasonography and MRI. Ultrasound Med Biol 24:683–688

    Article  Google Scholar 

  16. Bakker J, Olree M, Kaatee R et al (1999) Renal volume measurements: accuracy and repeatability of US compared with that of MR imaging. Radiology 211:623–628

    Article  CAS  Google Scholar 

  17. O’Neill WC, Robbin ML, Bae KT et al (2005) Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP). Am J Kidney Dis 46:1058–1064

    Article  Google Scholar 

  18. Hammoud S, Tissier AM, Elie C et al (2015) Ultrasonographic renal volume measurements in early autosomal dominant polycystic disease: comparison with CT-scan renal volume calculations. Diagn Interv Imaging 96:65–71

    Article  CAS  Google Scholar 

  19. Edell SL, Kurtz AB, Rifkin MD (1990) Normal renal ultrasound measurements. In: Goldberg BB, Kurtz AB (eds) Atlas of ultrasound measurements. Mosby- Year Book Chigago

  20. Kim HC, Yang DM, Lee SH, Cho YD (2008) Usefulness of renal volume measurements obtained by a 3-dimensional sonographic transducer with matrix electronic arrays. J Ultrasound Med 27:1673–1681

    Article  Google Scholar 

  21. Kim HC, Yang DM, Jin W, Lee SH (2010) Relation between total renal volume and renal function: usefulness of 3D sonographic measurements with a matrix array transducer. AJR Am J Roentgenol 194:W186–W192

    Article  Google Scholar 

  22. Riccabona M, Fritz GA, Schöllnast H, Schwarz T, Deutschmann MJ, Mache CJ (2005) Hydronephrotic kidney: pediatric three-dimensional US for relative renal size assessment—initial experience. Radiology 236:276–283

    Article  Google Scholar 

  23. Brancaforte A, Serantoni S, Silva Barbosa F, Di Leo G, Sardanelli F, Cornalba GP (2011) Renal volume assessment with 3D ultrasound. Radiol Med 116:1095–1104

    Article  CAS  Google Scholar 

  24. Breysem L, De Rechter S, De Keyzer F et al (2018) 3DUS as an alternative to MRI for measuring renal volume in children with autosomal dominant polycystic kidney disease. Pediatr Nephrol 33:827–835

    Article  Google Scholar 

  25. Kelcz F, Pozniak MA, Pirsch JD, Oberly TD (1990) Pyramidal appearance and resistive index: insensitive and nonspecific sonographic indicators of renal transplant rejection. AJR Am J Roentgenol 155:531–535

    Article  CAS  Google Scholar 

  26. Chen P, Maklad N, Redwine M (1998) Color and power Doppler imaging of the kidneys. World J Urol 16:41–45

    Article  CAS  Google Scholar 

  27. Afsar B, Elsurer R (2017) Increased renal resistive index in type 2 diabetes: clinical relevance, mechanisms and future directions. Diabetes Metab Syndr 11:291–296

    Article  Google Scholar 

  28. Hanamura K, Tojo A, Kinugasa S, Asaba K, Fujita T (2012) The resistive index is a marker of renal function, pathology, prognosis, and responsiveness to steroid therapy in chronic kidney disease patients. Int J Nephrol 2012:139565

    Article  Google Scholar 

  29. Parolini C, Noce A, Staffolani E, Giarrizzo GF, Costanzi S, Splendiani G (2009) Renal resistive index and long-term outcome in chronic nephropathies. Radiology 252:888–896

    Article  Google Scholar 

  30. Brkljacic B, Sabljar-Matovinovic M, Putarek K, Soldo D, Morovic-Vergles J, Hauser M (1997) Renal vascular resistance in autosomal dominant polycystic kidney disease. Evaluation with color Doppler ultrasound. Acta Radiol 38:840–846

    CAS  PubMed  Google Scholar 

  31. Kondo A, Akakura K, Ito H (2001) Assessment of renal function with color Doppler ultrasound in autosomal dominant polycystic kidney disease. Int J Urol 8:95–98

    Article  CAS  Google Scholar 

  32. Parfrey PS, Bear JC, Morgan J et al (1990) The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med 323:1086–1090

    Article  Google Scholar 

  33. Gabow PA, Schrier RW (1989) Pathophysiology of adult polycystic kidney disease. Adv Nephrol 18:19–32

    CAS  Google Scholar 

  34. King BF, Torres VE, Brummer ME et al (2003) Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal dominant polycystic kidney disease. Kidney Int 64:2214–2221

    Article  Google Scholar 

Download references

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hakan İmamoğlu.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Hakan İmamoğlu.

Conflict of interest

The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

Statistics and biometry

Two of the authors have significant statistical expertise.

Informed consent

Written informed consent was obtained from all subjects (patients) in this study.

Ethical approval

Institutional Review Board approval was obtained.

Methodology

• prospective

• diagnostic or prognostic study

• performed at one institution

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

İmamoğlu, H., Zararsız, G., Doğan, S. et al. Autosomal dominant polycystic kidney disease: new role for ultrasound. Eur Radiol 29, 5991–5998 (2019). https://doi.org/10.1007/s00330-019-06238-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-019-06238-0

Keywords

Navigation